Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis

NCT04741464 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Deep Vein Thrombosis
Inflammatory Response

Interventions

DRUG: Tinzaparin

Sponsor

Centre Hospitalier Universitaire, Amiens